Forbes – Heart Failure: The Missing 800 Pound Gorilla In Diabetes Trials

It was long believed that by virtue of their glucose-lowering properties diabetes drugs would confer substantial cardiovascular benefits. Now, however, that belief is no longer widely held and the FDA now requires cardiovascular outcome trials for new diabetes drugs.

Read more

Posted in Drugs Medical Research